Susquehanna International Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.8M Buy
1,033,109
+477,139
+86% +$38.2M 0.01% 1095
2025
Q4
$53M Buy
555,970
+73,413
+15% +$7.2M 0.01% 1315
2025
Q3
$47.1M Buy
482,557
+183,670
+61% +$19M 0.01% 1387
2025
Q2
$32.1M Buy
298,887
+166,984
+127% +$16.9M ﹤0.01% 1546
2025
Q1
$13.3M Sell
131,903
-493,807
-79% -$49.7M ﹤0.01% 2182
2024
Q4
$55.9M Buy
625,710
+174,769
+39% +$15.4M 0.01% 1030
2024
Q3
$37.8M Buy
450,941
+66,053
+17% +$5.21M 0.01% 1289
2024
Q2
$29.6M Buy
384,888
+4,371
+1% +$320K 0.01% 1371
2024
Q1
$26.1M Sell
380,517
-340,829
-47% -$21.9M ﹤0.01% 1526
2023
Q4
$41.7M Sell
721,346
-329,400
-31% -$17.6M 0.01% 1160
2023
Q3
$55.5M Buy
1,050,746
+153,903
+17% +$8.07M 0.01% 944
2023
Q2
$48.5M Sell
896,843
-610,838
-41% -$31.9M 0.01% 1020
2023
Q1
$75.4M Buy
1,507,681
+935,727
+164% +$44.1M 0.02% 725
2022
Q4
$26.5M Buy
571,954
+508,728
+805% +$22M 0.01% 1291
2022
Q3
$2.45M Sell
63,226
-147,271
-70% -$5.91M ﹤0.01% 4513
2022
Q2
$7.84M Sell
210,497
-206,921
-50% -$8.42M ﹤0.01% 2536
2022
Q1
$18.5M Sell
417,418
-52,185
-11% -$2.26M ﹤0.01% 1815
2021
Q4
$19.9M Buy
469,603
+176,927
+60% +$7.43M ﹤0.01% 1855
2021
Q3
$12.7M Sell
292,676
-717,871
-71% -$31.8M ﹤0.01% 2544
2021
Q2
$43.2M Buy
1,010,547
+525,637
+108% +$22.1M 0.01% 1305
2021
Q1
$18.7M Sell
484,910
-427,258
-47% -$16.2M ﹤0.01% 1951
2020
Q4
$32.8M Buy
912,168
+648,470
+246% +$23.4M 0.01% 1298
2020
Q3
$10.1M Sell
263,698
-980,668
-79% -$37.8M ﹤0.01% 2164
2020
Q2
$43.7M Buy
1,244,366
+339,150
+37% +$12.2M 0.01% 904
2020
Q1
$29.5M Buy
905,216
+562,132
+164% +$22M 0.01% 948
2019
Q4
$15.5M Buy
343,084
+203,560
+146% +$8.52M ﹤0.01% 1659
2019
Q3
$5.68M Sell
139,524
-824,805
-86% -$34.9M ﹤0.01% 2552
2019
Q2
$41.4M Buy
+964,329
New +$37.1M 0.02% 798
2018
Q3
Sell
-9,308
Closed -$325K 9237
2018
Q2
$304K Sell
9,308
-12,200
-57% -$368K ﹤0.01% 7815
2018
Q1
$588K Sell
21,508
-428,063
-95% -$11.6M ﹤0.01% 6294
2017
Q4
$11.1M Buy
449,571
+427,105
+1,901% +$11.8M ﹤0.01% 1732
2017
Q3
$655K Buy
+22,466
New +$620K ﹤0.01% 6046
2017
Q2
Sell
-163,142
Closed -$4.33M 9206
2017
Q1
$4.06M Sell
163,142
-240,636
-60% -$5.85M ﹤0.01% 2592
2016
Q4
$8.73M Buy
+403,778
New +$8.81M ﹤0.01% 1695
2016
Q3
Sell
-134,542
Closed -$3.21M 8410
2016
Q2
$3.14M Buy
134,542
+78,517
+140% +$1.7M ﹤0.01% 2866
2016
Q1
$1.05M Sell
56,025
-324,229
-85% -$5.7M ﹤0.01% 4985
2015
Q4
$7.01M Sell
380,254
-3,376
-0.9% -$60.5K ﹤0.01% 2118
2015
Q3
$6.3M Buy
383,630
+46,242
+14% +$790K ﹤0.01% 2359
2015
Q2
$5.97M Sell
337,388
-26,590
-7% -$475K ﹤0.01% 2646
2015
Q1
$6.46M Buy
363,978
+144,330
+66% +$2.28M ﹤0.01% 2387
2014
Q4
$2.91M Sell
219,648
-28,166
-11% -$360K ﹤0.01% 3799
2014
Q3
$2.93M Sell
247,814
-156,531
-39% -$1.97M ﹤0.01% 3946
2014
Q2
$5.16M Sell
404,345
-186,350
-32% -$2.42M ﹤0.01% 3021
2014
Q1
$7.99M Sell
590,695
-655,756
-53% -$8.61M ﹤0.01% 2280
2013
Q4
$15M Buy
1,246,451
+283,478
+29% +$3.35M 0.01% 1651
2013
Q3
$11.3M Buy
962,973
+483,863
+101% +$5.23M 0.01% 1778
2013
Q2
$4.44M Buy
+479,110
New +$4.06M ﹤0.01% 2772

Other funds holding BSX

Susquehanna International Group's BSX Position: Q1 2026 in Review

Susquehanna International Group increased its Boston Scientific (BSX) stake by 86% in Q1 2026, buying an estimated $38.2M and bringing the position to 1,033,109 shares worth $64.8M. The position accounts for 0.01% of the portfolio, ranked #1095.

Susquehanna International Group first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $75.4M in Q1 2023. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Susquehanna International Group held 1,033,109 shares of Boston Scientific worth $64.8M as of Q1 2026.
  • Susquehanna International Group bought 477,139 Boston Scientific shares in Q1 2026, an estimated $38.2M.
  • Boston Scientific made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1095 holding.
  • Susquehanna International Group first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Boston Scientific position peaked at $75.4M in Q1 2023.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.